Omthera Pharmaceuticals Inc (NASDAQ:OMTH) Investor Alert: Lawsuit Against Takeover for $12.70
An investor, who currently holds NASDAQ:OMTH shares, filed a lawsuit in effort to stop the takeover of Omthera Pharmaceuticals Inc by AstraZeneca, for $12.70 per NASDAQ:OMTH share.
View full press release